MOTIVATE, Study of Treating Hemophilia A With Inhibitors, Enrolls 1st US Patient

MOTIVATE, Study of Treating Hemophilia A With Inhibitors, Enrolls 1st US Patient

295515

MOTIVATE, Study of Treating Hemophilia A With Inhibitors, Enrolls 1st US Patient

A first patient in the U.S. has enrolled in a multinational study to collect real-world data on different approaches in managing hemophilia A in people with inhibitors, with an aim of understanding how treatment decisions affect patients. The investigator-led MOTIVATE study (NCT04023019; EudraCT No. 2019-003427-38) is recruiting up to 120 children and adults in the U.S. and Germany. Sites may also open in Canada. “We are very excited that patient enrollment in MOTIVATE has begun in the…

You must be logged in to read/download the full post.